HM Medical Clinic

Take Clomid is contraindicated in the presence of cysts in the ovaries, liver and kidney failure, the presence of pituitary tumors or genital organs clomid cost Before using the product you should consult with a specialist and to get acquainted with the instructions approved by the manufacturer.

Cialis ne doit pas être prise à tous. Il est important que cialis en ligne est prescrit par un médecin, bien se familiariser avec les antécédents médicaux du patient. Ich habe Probleme mit schnellen Montage. Lesen Sie Testberichte Nahm wie cialis rezeptfrei 30 Minuten vor dem Sex, ohne Erfolg. Beginn der Arbeiten nach 4 Stunden, links ein Freund ein trauriges Ja, und Schwanz in sich selbst nicht ausstehen, wenn es keinen Wunsch ist.

Ifip newsletter issue 061406 (read-only)




July 2006
June 2006
Volume 1, Issue 2
Official Newsletter o f the Ru tgers Ins titu te for P harmaceutica l Indust ry Fello wshi ps Official Newsletter of the Rutgers Institute for Pharmaceutical Industry Fellowships Message from the Co-Chief Fellows
Message from the Editors:
Anish Patel & Na Young Goh This is our End-of-the-Year issue of the RPIF Newsletter. Through this will: i) increase interactions stakeholders together and edition, we hope to reflect upon the among fellows & alumni, ii) provide top-line information amazing fellowship year as well as provide fellows with an oppor- of fellow's accomplishments provide insight to the next year. tunity to maintain activities and program milestones. Through the newsletter, we hope to throughout the year, and iii) Overall, these committees promote continued involvement and give back to our community. will provide fellows with an success for the new year! Through the creation of two new increased scope of opportuni- Thank you to everyone that contrib- committees, Community Devel- ties to stay involved through- uted to this issue and congrats to all opment and Newsletter, we hope out the year. For the success the graduating fellows and welcome to strive towards a successful of our committees and pro- to all the incoming fellows!! year in accomplishing these gram, the fellows are encour- -Maricel & Jennifer goals. The Community Devel- aged to be involved and en- opment Committee headed up thusiastic in our mission. Dear Fellows & Alumni, by Angela Stevenson was estab- As the year processes, we lished to build relationships welcome new ideas to im- between fellows, alumni, and Featuring:
Welcome to our new fellows prove and enhance the pro- our community. This committee and congratulation to our con- gram. Should you have any End of the Year Collage
is challenged to not only provide tinuing fellows on completing questions or concerns, please fellows with the opportunity to Alumni Spotlight
their first year in the program. let us know. Your involve- collaborate with alumni, but also Certificate Dinner
We are excited to kick-off this ment and commitment to the serve as a philanthropic resource upcoming year, which is prom- program is appreciated Welcome New Fellows
to our community. ising to be filled with fun activi- Furthermore, the Newsletter Mark Your Calendars
ties as well as some challenging Committee under the leadership Anish Patel & Na Young Goh of Maricel DeJesus and Jennifer We hope the year ahead of us Kim will better connect our 2006-2007 RPIF Committees
Newsletter
Committee Chair(s) Amy Patel & Madonna Krawczyk Coordination of all aspects of ASHP Meeting • Lead contacts from
each company are
University Outreach Jessica Winnie & John Vaile Organization of recruitment visits to Universities and Colleges needed! If interested
please contact:

Organization Outreach Coordination of RFIP representation at pharmacy associations Jennifer Kim
Fellowship Information Day Coordination of FID to increase awareness of RFIP Maintain integrity and content of RPIF website Maricel DeJesus
Coordination of courses and provide teaching opportunities at Rutgers Pharmacy School Marcel DeJesus & Jennifer Kim Connect RPIF Community through newsletter Community Development Angela Stevenson Build relationships with students & alumni and community outreach






The Fellowship Chronicles Volume 1, Issue 2 A Year To Remember
Congratulations to the Graduating Fellows
We wish you the best of luck!
Bristol Myers Squibb:
Novartis:
Ortho McNeil Janssen:
Hoffman La Roche:
Erika Massenburg Tibotec:
Vinod Kalathiveetil Nana Wiafe-Ababio Antonella Lozito Staci Lymperopoulos The Fellowship Chronicles Volume 1, Issue 2 Alumni Connection
From "In Focus– Profiles from our Alumni" For more info, see http://pharmafellows.rutgers.edu/locked/alumni-infocus.php Bardia Akbari, PharmD
By Buu Chung, PharmD
you love to do, then you'll be really Key Advices:
studies than what are currently being done in the industry—I guess Establish relationships you can call it the pursuit of a Bardia participated in a two-year ‘perfect' clinical development pro- clinical research fellowship at Hoff- • Learn to align scientific mann La-Roche through the Rutgers and business visions Pharmaceutical Industry Fellowship • Program. Upon completion, Bardia Seek out a mentor decided to stay with Hoffmann La- • Rotate with FDA Operations Project Leader, Roche as a Clinical Science Special-ist. He later assumed other internal • Success in Clinical dept Clinical Team Leader positions prior to being promoted to involves organization, de- his current position as Operations tail-orientation, and under- Hoffmann-La Roche Dr. Akbari was introduced to the Project Leader, Clinical Team standing the work instead pharmaceutical industry early on Leader. Roche-Rutgers Fellowship Director in his career. While at the Uni- Bardia's most memorable fellowship versity of Colorado, he com- • Develop skills to market FELLOWSHIP YEARS experience was during his second pleted summer internship at year. He and his team were working yourself for a position Glaxo (now known as GlaxoS- on a pediatric compound in develop- Bardia aspires to have a perfect FELLOWSHIP COMPANY mithKline). At Glaxo, he had the ment for a pediatric indication. Upon clinical trial, where there's no extra opportunity to rotate in various administration to 10-year old patient, Hoffmann– La Roche patient enrolled in the study and departments, and became most he saw the immediate impact that not an extra dollar is spent unnec- intrigued with clinical research. FELLOWSHIP DISCIPLINES the drug had on the child. "Making essarily—everything is done per- This inspired him to earn his Clinical Investigations a difference in others' lives is not fectly. "My career goal is to be in PharmD degree and pursue ca- always visible but that's what we, as a position where I can influence a reer in pharmaceutical industry. a pharmaceutical industry, are trying much more efficient and effective University of Colorado (BS Pharm), Bardia believes: "If you do what to do." way of conducting clinical trial SUNY Buffalo (PharmD) Irene Laurora, PharmD
By Maricel DeJesus, PharmD
Upon receiving her B.S. degree switch projects and participated in company in a significant way. from St. John's University and her the Zantac 75 switch. From there, Irene's advice to the fellows is to Doctor of Pharmacy degree from she moved to Parke-Davis. Here "gain your own experience." the Medical College of Virginia, Irene was involved with the Lipitor You have to experience things Irene Laurora knew she wanted to launch by leading one of Lipitor's for yourself before you really pursue a career in clinical research. largest primary care trials. After- know what something entails. Though the fellowship at Sandoz, wards, she transferred back to War- she was able to pave the way to ner-Lambert to head the Rx-to-OTC Despite her busy career and pre- Director, Medical/Clinical Research many opportunities. switch clinical efforts. cepting fellows, Irene balances her personal life. She and her Through her fellowship in clinical Throughout her successful career, husband, Nick have two lovely Pfizer Consumer Healthcare research, Irene was involved with Irene has been involved with manag- children, Christopher and Nicho- monitoring sites, writing study ing many clinical trials mostly in- las. She is very involved in her protocols, and interacting with volving Rx to OTC switches. She Medical/Clinical Preceptor children's activities. people in various departments. She loves what she does. She thinks FELLOWSHIP YEARS was able to develop her skills in "clinical research is a nice mix of presenting as well as persuasive clinical medicine, research, under- UPCOMING FEATURES:
FELLOWSHIP COMPANY writing. Most importantly, she was standing and interpreting regula- able to further develop her critical tions, medical writing, and support- Laura Fields,
thinking skills and apply her ac- ing marketing efforts. It is a very FELLOWSHIP DISCIPLINES quired knowledge to her job. goal-oriented field." Market Development,
Rimonabant
After her fellowship, Irene took a Irene's future goals are to be more job at Warner-Lambert. There she involved with strategic business and St. John's University; Medical College of was involved with the Rx-to-OTC decision making that will impact the The Fellowship Chronicles Volume 1, Issue 2 Official Newsletter of the Rutgers Institute for Pharmaceutical Industry Fellowships 2006 RPIF Certificate Dinner
The Rutgers Institute for Pharmaceutical Industry 2006 co-chief fellows, Staci Lymperopoulos and Fellowships held their annual certificate dinner Lucio Volino. Guest speakers included Cathy Segal on Thursday, June 8th at the Hilton Short Hills. and…. from BMS. They bought gave inspirational Fellows, preceptors, alumni, and family members and thoughtful speeches. After dinner, the graduat- of fellows were all gathered to celebrate the com- ing fellows received their completion certificate and pletion of the fellowship program but celebrating the night ended with a slide show presentation of the start of their professional career. this past year made by next year's Co-chief fellow Na Young Goh. The night was spent with fellow colleagues shar-ing fond memories from this past year and for We would like to congratulate the graduating fel- some of the fellows, saying their farewells as lows and wish you the best of luck with your new they part in their separate ways. Speakers from the night included Program Direc-tors, Dr. Alexander and Dr. Barone and 2005- Welcome to the New Incoming Fellows
Novartis:
John McBride, Tammy Dang Suzanne Maahs, Stephanie Whalen, Les- Chhaya Shah, Jessica Ford lie Servidio, Dale Butterfloss, Vanessa Kan, Chris Sung, Melina Cioffi, Kathy Lisa Varghese, Nissa Pisano Dong, Melody Magliano Drilon Saliu, Melissa Gallo, Manita Singh, Nikul Shukla Bristol Myers Squibb:
Schering Plough:
Amit Duggal, Arpan Shah, Annette Gbemudu, John Holt, Jennifer Stover, Robert Adamczk, Elizabeth Lucini, Bhav- Ortho McNeil Janssen:
James Lau, Chinedu Momah, Tiffany Marsh, Stacy Matthew, Nanrita Nandra, Mary Cheriyan, Tony Lan, Robert James, Tibotec:
Christine Ghobrial, Joe Jiang Hoffman La Roche:
Neelam Patel, Salah El-Saheb, Scott Ramona Derkits, Eunice Chung Adamczk, Ami Patel, Mohammed Issa, Natanya Jennings, Jay Paul Singh Scientific Advantage Award Recipients
Congratulations to Anish Patel, Pharm.D. and Jessica Winnie, Pharm.D. on winning the PharmD
Mark Your Calendars!
Fellowship Award from Scientific Advantage. Scientific Advantage is an integrated company that helps build, model, train and refine Medical Sci- ROPES Course
ence Liaison teams. They work with pharmaceutical, biotech and medical device companies to ex-pand and dramatically improve their medical marketing impact. Recently, Scientific Advantage invited all of the Rutgers Fellows who were interested in pursuing a career as an MSL to apply for the PharmD Fellowship Award. The recipients were able to attend the Annual Scientific Advantage First Professional Development Day
Medical Science Liason Seminar On April 25-26. According to Jessica Winnie, ""Attending the meeting was a great experience. I learned a great deal about the regulations governing the role of an MSL, the opportunities for career development in the MSL role, and I had a chance to network with and meet many past, current and future MSLs. I would recommend this meeting for all those interested in pursuing a career as an MSL, and I look forward to the future collaboration of Scientific Advantage and the Rutgers Fellowship." S Editors: Jennifer Kim, Maricel DeJesus
Contact:
T Contributors: Buu Chung, Na Young Goh, Anish Patel, Jessica Winnie
Ernest Mario School of Pharmacy A Advisor: Dr. James Alexander
Rutgers, The State University of New Jersey 160 Frelinghuysen Road, Room 405 Phone: (732) 445-5215 ext. 455 Special Thanks to- Svetlana Kurinsky

Source: http://pharmafellows.rutgers.edu/resources/51fc8281d308931dfc3e2d776dc2f244.pdf

oceanpublishing.ie

OFFICE OF PUBLIC WORKS Before the Deluge Tony Smyth, Director of Engineering Services and Chief Engineer in the Office of Public Works, talks John Walshe through the OPW's efforts to revolutionise flood risk management in Ireland via the Catchment Flood Risk Assessment and Management (CFRAM) programme. The CFRAM programme is set EU FLOODS DIRECTIvE

ucp.pt

Copyright 2007 by the American Psychological Association 2007, Vol. 7, No. 4, 745–754 Functional Magnetic Resonance Imaging Responses Relate to Differences in Real-World Social Experience Naomi I. Eisenberger, Shelly L. Gable, and Matthew D. Lieberman University of California, Los Angeles Although neuroimaging techniques have proven powerful in assessing neural responses, little is knownabout whether scanner-based neural activity relates to real-world psychological experience. A jointfunctional magnetic resonance imaging (fMRI)/experience-sampling study investigated whether individ-ual differences in neurocognitive reactivity to scanner-based social rejection related to: (a) moment-to-moment feelings of social rejection during real-world social interactions ("momentary social distress")and (b) the extent to which these momentary feelings corresponded with end-of-day global assessmentsof social disconnection ("end-of-day social disconnection"). Individuals who showed greater activity inregions associated with affective and pain processing (dorsal anterior cingulate cortex, amygdala,periaqueductal gray) during scanner-based social rejection reported feeling greater momentary socialdistress during their daily social interactions. In contrast, individuals who showed greater activity inregions associated with memory and self-referential memory encoding (hippocampus, medial prefrontalcortex) showed a stronger correspondence between momentary social distress and end-of-day socialdisconnection, such that greater momentary social distress was associated with greater end-of-day socialdisconnection. These findings complement previous work showing a dissociation between momentaryand retrospective reports of affect and suggest that these processes rely on dissociable neural systems.